期刊名称：RADIOLOGY AND ONCOLOGY ISSN： 1318-2099 出版频率： Quarterly 出版社： WALTER DE GRUYTER GMBH, GENTHINER STRASSE 13, BERLIN, GERMANY, D-10785   出版社网址： http://www.astro.org/ 期刊网址： http://versita.metapress.com/content/120729/ 影响因子： 2.991 主题范畴： ONCOLOGY;    RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Description Radiology and Oncology is a journal devoted to publication of original contributions in diagnostic and interventional radiology, computerized tomography, ultrasound, magnetic resonance, nuclear medicine, radiotherapy, clinical and experimental oncology, radiobiology, radiophysics and radiation protection. Instructions to Authors Instructions for authors   The editorial policy of the journal Radiology and Oncology is to publish original scientific papers, professional papers, review articles case reports and varia (editorials, short communications, professional information, book reviews, letters, etc.) pertinent to diagnostic and interventional radiology, computerized tomography, magnetic resonance, ultrasound, nuclear medicine, radiotherapy, clinical and experimental oncology, radiobiology, radiophysics and radiation protection. The Editorial Board requires that the paper has not been published or submitted for publication elsewhere; the authors are responsible for all statements in their papers. Accepted articles become the property of the journal and therefore cannot be published elsewhere without written permission from the editorial board. Papers concerning the work on humans must comply with the principles of the declaration of Helsinki (1964). The approval of the ethical committee must then be stated on the manuscript. Papers with questionable justification will be rejected.   The manuscript written in English should be submitted to the Editorial Office Radiology and Oncology, Institute of Oncology Ljubljana, Zaloska 2, SI-1000 Ljubljana, Slovenia; (Phone: +386 (0)1 5879 369, Tel./Fax: +386 (0)1 5879 434, E-mail: gsersa@onko-i.si). Authors are also asked to submit their manuscripts electronically to: gsersa@onko-i.si. A printed copy along with the manuscript on CD should be sent to the editorial office. The type of computer and word-processing package should be specified (Word for Windows is preferred).   All articles are subjected to editorial review and review by independent referees selected by the editorial board. Manuscripts which do not comply with the technical requirements stated herein will be returned to the authors for correction before peer-review. The editorial board reserves the right to ask authors to make appropriate changes in the contents as well as grammatical and stylistic corrections when necessary. The expenses of additional editorial work and requests for additional reprints will be charged to the authors.   General instructions Radiology and Oncology will consider manuscripts prepared according to the Vancouver Agreement (N Engl J Med 1991; 324: 424-8, BMJ 1991; 302: 6772; JAMA 1997; 277: 927-34.).The manuscript should be typed double-spaced with a 3-cm margin at the top and left-hand side of the sheet. The paper should be written in grammatically and stylistically correct language. Abbreviations should be avoided unless previously explained. The technical data should conform to the SI system. The manuscript, including the references, must not exceed 20 typewritten pages, and the number of figures and tables is limited to 8. If appropriate, organize the text so that it includes: Introduction, Materials and methods, Results and Discussion. Exceptionally, the results and discussion can be combined in a single section. Start each section on a new page, and number each page consecutively with Arabic numerals.   The title page should include a concise and informative title, followed by the full name(s) of the author(s); the institutional affiliation of each author; the name and address of the corresponding author (including telephone, fax and E-mail), and an abbreviated title. This should be followed by the abstract page, summarizing in less than 250 words the reasons for the study, experimental approach, the major findings (with specific data if possible), and the principal conclusions, and providing 3-6 key words for indexing purposes. Structured abstracts are preferred. The text of the report should then proceed as follows:   Introduction should state the purpose of the article and summarize the rationale for the study or observation, citing only the essential references and stating the aim of the study.   Materials and methods should provide enough information to enable experiments to be repeated. New methods should be described in detail. Reports on human and animal subjects should include a statement that ethical approval of the study was obtained.   Results should be presented clearly and concisely without repeating the data in the figures and tables. Emphasis should be on clear and precise presentation of results and their significance in relation to the aim of the investigation.   Discussion should explain the results rather than simply repeating them and interpret their significance and draw conclusions. It should review the results of the study in the light of previously published work.   Illustrations and tables must be numbered and referred to in the text, with the appropriate location indicated. Graphs and photographs, provided electronically, should be of appropriate quality for good reproduction. Colour graphs and photographs are encouraged. In photographs, mask the identities of the patients. Tables should be typed double-spaced, with a descriptive title and, if appropriate, units of numerical measurements included in the column heading.   References must be numbered in the order in which they appear in the text and their corresponding numbers quoted in the text. Authors are responsible for the accuracy of their references. References to the Abstracts and Letters to the Editor must be identified as such. Citation of papers in preparation or submitted for publication, unpublished observations, and personal communications should not be included in the reference list. If essential, such material may be incorporated in the appropriate place in the text. References follow the style of Index Medicus. All authors should be listed when their number does not exceed six; when there are seven or more authors, the first six listed are followed by "et al.". The following are some examples of references from articles, books and book chapters:   Dent RAG, Cole P. In vitro maturation of monocytes in squamous carcinoma of the lung. Br J Cancer 1981; 43: 486-95.   Chapman S, Nakielny R. A guide to radiological procedures. London: Bailliere Tindall; 1986.   Evans R, Alexander P. Mechanisms of extracellular killing of nucleated mammalian cells by macrophages. In: Nelson DS, editor. Immunobiology of macrophage. New York: Academic Press; 1976. p. 45-74.   Page proofs will be sent by E-mail or faxed to the corresponding author. It is their responsibility to check the proofs carefully and return a list of essential corrections to the editorial office within 48 hours of receipt. If corrections are not received by the stated deadline, proof-reading will be carried out by the editors.   Reprints. The electronic version of the published papers will be available on http://www.onko-i.si/radioloncol Editorial Board Editors Editor-in-Chief: Gregor SerÅ¡a, Institute of Oncology Ljubljana, Ljubljana, Slovenia Executive Editor: Viljem Kovač, Institute of Oncology Ljubljana, Ljubljana, Slovenia Deputy Editors: Andrej Cör, University of Ljubljana, Medical Faculty, Ljubljana, Slovenia Igor Kocijančič, Clinical Centre Ljubljana, Institute of Radiology, Ljubljana, Slovenia Editorial Board Karl H. Bohuslavizki, Nuklearmedizin Spitalerhof, Hamburg, Germany Maja ÄŒemažar, Institute of Oncology Ljubljana, Department of Experimental Oncology, Ljubljana, Slovenia Christian Dittrich, Ludwig Boltzmann-Institute for Applied Cancer Research, Kaiser Franz Josef - Spital, Vienna, Austria Metka Filipič, National Institute of Biology, Department of Genetic Toxicology and Cancer Biology, Ljubljana, Slovenia Tullio Giraldi, Faculty of Medicine, University of Trieste, Trieste, Italy Maria GÅ‘dény, Department of Radio-Diagnostics, National Institute of Oncology, Budapest, Hungary Vassil Hadjidekov, Department of Radiology, University Hospital "Alexandrovska", Sofia, Bulgaria Marko Hočevar, Institute of Oncology Ljubljana, Department of Surgical Oncology, Ljubljana, Slovenia Maksimilijan Kadivec, Institute of Oncology Ljubljana, Department of Radiology, Ljubljana, Slovenia Miklós Kásler, National Institute of Oncology, Budapest, Hungary Michael Kirschfink, Universitätsklinikum Heidelberg, Institut für Immunologie, Heidelberg, Germany Janko Kos, University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia Tamara Lah TurnÅ¡ek, National Institute of Biology, Ljubljana, Slovenia Damijan Miklavčič, University of Ljubljana, Faculty of Electrical Engineering, Ljubljana, Slovenia Luka Milas, UT M. D. Anderson Cancer Center, Houston , USA Damir Miletić, University Hospital Rijeka, Department of Radiology, Rijeka, Croatia Maja Osmak, Ruder BoÅ¡ković Institute, Department of Molecular Biology, Zagreb, Croatia Branko Palčič, BC Cancer Research Centre, Vancouver, Canada DuÅ¡an Pavčnik, Oregon Health & Science Institute, Oregon, USA, Portland, USA Geoffrey J. Pilkington, University of Portsmouth, School of Pharmacy & Biomedical Sciences, Portsmouth , UK Ervin B. PodgorÅ¡ak, McGill University, Montreal, Canada UroÅ¡ Smrdel, Institute of Oncology Ljubljana, Department of Radiation Oncology, Ljubljana, Slovenia Primož Strojan, Institute of Oncology, Department of Radiation Oncology, Ljubljana, Slovenia Borut Å tabuc, Clinical Center Ljubljana, Ljubljana, Slovenia Ranka Å tern-Padovan, Clinical Hospital Center Zagreb, Clinical Department of Diagnostic and Interventional Radiology, Zagreb, Croatia Justin Teissié, DR1 CNRS, IPBS CNRS, Tolouse, France Sándor Tóth, Orosháza City Hospital, Transfusiology Unit, Orosháza , Hungary Gillian Tozer, University of Sheffield, Academic Unit of Surgical Oncology, Royal Hallamshire Hospital, Sheffield, UK Andrea Veronesi, Centro di Riferimento Oncologico- Aviano, Division of Medical Oncology, Aviano, Italy Branko Zakotnik, Institute of Oncology Ljubljana, Department of Medical Oncology, Ljubljana, Slovenia   Language Editor Vida KoloÅ¡a, Association of Radiology and Oncology, Ljubljana, Slovenia   Technical Editors Matjaž Lužar, Association of Radiology and Oncology, Ljubljana, Slovenia